HR 5333 · 115th Congress 2017–2019, ended

Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018

Latest action · Jul 17, 2018 Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 19, 2018
  2. Passed HouseJul 16, 2018
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018

This bill amends the Federal Food, Drug, and Cosmetic Act to substantially revise how over-the-counter (OTC) drugs are approved.

Cosponsors 8

Members who signed on, in the order they did. Signatures ran from Mar 19, 2018 to Jul 10, 2018; 5 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-KYBrett GuthrieOriginalMar 19, 2018
D-MIDebbie DingellOriginalMar 19, 2018
D-CODiana DeGetteOriginalMar 19, 2018
D-TXGene GreenOriginalMar 19, 2018
R-TXMichael C. BurgessOriginalMar 19, 2018
D-CADoris O. MatsuiMay 15, 2018
R-TNCharles J. "Chuck" FleischmannMay 18, 2018
D-ORKurt SchraderJul 10, 2018

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 19, 2018Markup May 9, 2018Reported Jul 16, 2018
Health Subcommittee
Referred Mar 23, 2018

Actions 13

Everything that happened, newest first.

  1. Jul 17, 2018Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518.
  2. Jul 16, 2018Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-827.
  3. Jul 16, 2018Placed on the Union Calendar, Calendar No. 640.
  4. Jul 16, 2018Mr. Latta moved to suspend the rules and pass the bill, as amended.
  5. Jul 16, 2018Considered under suspension of the rules. (consideration: CR H6227-6237)
  6. Jul 16, 2018DEBATE - The House proceeded with forty minutes of debate on H.R. 5333.
  7. Jul 16, 2018Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6227-6235)
  8. Jul 16, 2018Motion to reconsider laid on the table Agreed to without objection.
  9. May 9, 2018Committee Consideration and Mark-up Session Held.
  10. May 9, 2018Ordered to be Reported (Amended) by Voice Vote.
  11. Mar 23, 2018Referred to the Subcommittee on Health.
  12. Mar 19, 2018Introduced in House
  13. Mar 19, 2018Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H6227–H6237Text printed H6227–H6235Debbie Dingell D-MI, Diana DeGette D-CO, Earl L. "Buddy" Carter R-GA, Gene Green D-TX, Michael C. Burgess R-TX, Robert E. Latta R-OHJul 16, 2018

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Congressional Budget Office cost estimate

  1. Jun 8, 2018H.R. 5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018As ordered reported by the House Committee on Energy and Commerce on May 9, 2018

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 3: Congress shall have the Power . . .'' to regulate Commerce with foreign Nations, and among the several States, and with the Indian tribes.''

The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 47, March 19, 2018, page H1698.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2315Over-the-Counter Drug Safety, Innovation, and Reform ActRelated billMay 14, 2018
HR 7328Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018Related billDec 20, 2018

Titles 7

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.
Short Titles as Introduced
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Short Titles as Reported to House
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Short Titles as Passed House
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Short Titles as Introduced for portions of this bill
Over-the-Counter Monograph User Fee Act of 2018
Short Titles as Reported to House for portions of this bill
Over-the-Counter Monograph User Fee Act of 2018
Short Titles as Passed House for portions of this bill
Over-the-Counter Monograph User Fee Act of 2018

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 4

Each version as it was printed, newest first.

  1. Jul 17, 2018Placed on Calendar Senate
  2. Jul 16, 2018Reported in House
  3. Jul 16, 2018Engrossed in House
  4. Mar 19, 2018Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.